Phase 4 N=66,228 Mortality Reduction After Oral Azithromycin Contingency: Mortality Study
Childhood Mortality
Primary: All-cause Mortality Rate in Children Aged 1-60 Months — 24.8; 26.7 deaths per 1000 person years
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=190,238 Mortality Reduction After Oral Azithromycin: Mortality Study
Childhood Mortality
Primary: All-cause Mortality Rate in Children Aged 1-60 Months — 14.6; 16.5 deaths per 1000 person-years
N/A N=778 Doctors' Understanding of Survival Statistics
Screening
Primary: Number of Physicians (=Participants) Recommending the Screening — 301 participants — p=<0.05
N/A N=5,834 European Mortality & Length Of Intensive Care Unit (ICU) Stay Evaluation (ELOISE)
Critical Illness
Primary: Vital Status at Hospital Discharge — 1232; 165 participants
N/A N=3,015,000 Morbid Rates After Spiriva Chronic Obstructive Pulmonary Disease (COPD) Protocol Change
Pulmonary Disease, Chronic Obstructive
Primary: Number of Hospital Admissions in Chronic Obstructive Pulmonary Disease (COPD) Patients — 665; 765 Hospitalizations — p=0.24
N/A N=500 Reducing Post-Hospital Mortality in HIV-infected Adults in Tanzania
HIV Infections
Primary: Number of Participant Deaths in the First 12 Months Post-hospitalization — 43; 42 Participants — p=0.91
N/A N=168 Predicting Mortality in Patients With Return of Spontaneous Circulation After Cardiac Arrest
Post-Resuscitation Syndrome · Critical Illness · Cardiac Arrest
Primary: 30-Day Mortality — 112 participants
N/A N=334 Independent Predictors of Mortality in Polytrauma Patients
Multiple Trauma
Primary: Death — 52 participants — p=< 0.001